| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/26/2009 | US20090082283 Dipeptides for Prevention of Muscle Breakdown and Microbial Infection |
| 03/26/2009 | US20090082279 Treating a condition associated with breakdown of the blood brain barrier by administering a peptide antagonist of zonulin that binds to the zonula occludens receptor, especially in the brain, yet does not physiologically modulate the opening of mammalian tight junctions |
| 03/26/2009 | US20090082274 Collections of repeat proteins comprising repeat modules |
| 03/26/2009 | US20090082268 Muteins of Placental Growth Factor Type I, Preparation Method And Application Thereof |
| 03/26/2009 | US20090082265 Compositions and methods for treating diseases |
| 03/26/2009 | US20090082261 Urea-containing peptides as inhibitors of viral replication |
| 03/26/2009 | US20090081792 Immune potentiating compositions of cancer cells |
| 03/26/2009 | US20090081780 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 03/26/2009 | US20090081732 Antibodies to human il-1beta |
| 03/26/2009 | US20090081729 Compositions and Methods Comprising a Ligand of ChemerinR |
| 03/26/2009 | US20090081314 Glycemic Control, Diabetes Treatment, and Other Treatments with Acetyl Cholinesterase Inhibitors |
| 03/26/2009 | US20090081302 Pulmonary delivery of polyene antifungal agents |
| 03/26/2009 | US20090081283 Tumor therapy with non-viral-based high affinitiy laminin receptor-targeted vectors |
| 03/26/2009 | US20090081257 Hydrogenase deficient bacterial strains |
| 03/26/2009 | US20090081253 Composition |
| 03/26/2009 | US20090081249 Bi-Functional Polymer-Attached Inhibitors of Influenza Virus |
| 03/26/2009 | US20090081241 comprising all of the heavy chain variable CDR regions of SEQ ID NOS:1, 2 and 3 and/or all of the light chain variable CDR regions of SEQ ID NOS:4, 5 and 6, specific for at least one human tumor necrosis factor alpha (TNF) protein |
| 03/26/2009 | US20090081239 bind and neutralize Plasminogen Activator Inhibitor-1 (PAI-1) by converting PAI-1 to its latent form or increasing proteolytic cleavage; treating a fibrotic condition; inhibits accumulation of extracellular matrix (ECM) |
| 03/26/2009 | US20090081238 Anti-notch1 NRR antibodies and methods using same |
| 03/26/2009 | US20090081230 Human cytomegalovirus neutralising antibodies and use thereof |
| 03/26/2009 | US20090081216 Treatment of pathologies which escape the immune response, using optimized antibodies |
| 03/26/2009 | US20090081214 Genetic products differentially expressed in tumors and use thereof |
| 03/26/2009 | US20090081207 High affinity human and humanized anti-alpha5beta1 integrin function blocking antibodies with reduced immunogenicity |
| 03/26/2009 | US20090081202 Immunogenic compositions and methods |
| 03/26/2009 | US20090081193 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 03/26/2009 | US20090081183 HIV Transcription Repressor Complex and Compositions and Methods Based Thereon |
| 03/26/2009 | US20090081180 Antimicrobial polymer conjugates |
| 03/26/2009 | US20090081172 Nucleic acid encoding a receptor other than an immunoglobulin, wherein the receptor binds to a MUC 1 tumor antigen independently of a major histocompatibility complex (MHC); activating a signaling pathway and/or killing a cancer cell using a receptor that is similar to or is a T cell receptor |
| 03/26/2009 | US20090081165 Bicyclic heteroaryl derivatives |
| 03/26/2009 | US20090081162 Method for downregulating an immune reaction |
| 03/26/2009 | US20090081158 Phosphadiazine hcv polymerase inhibitors iv |
| 03/26/2009 | US20090081131 Tumor therapy with high affinity laminin receptor-targeted vectors and compounds |
| 03/26/2009 | US20090081124 Virus coat protein/receptor chimeras and methods of use |
| 03/26/2009 | CA2849420A1 Anti-infective pyrimidines and uses thereof |
| 03/26/2009 | CA2700302A1 Compositions comprising siraitia grosvenori extracts and methods for the treatment of infection |
| 03/26/2009 | CA2700263A1 Soluble dosage forms containing cephem derivatives suitable for parenteral administration |
| 03/26/2009 | CA2700115A1 Long interspersed nuclear element polypeptide compositions and methods of use thereof |
| 03/26/2009 | CA2699989A1 N-phenyl-dioxo-hydro pyrimidines useful as hepatitis c virus (hcv) inhibitor |
| 03/26/2009 | CA2699986A1 Anti-infective pyrimidines and uses thereof |
| 03/26/2009 | CA2699981A1 Uracil or thymine derivative for treating hepatitis c |
| 03/26/2009 | CA2699817A1 Benzimidazole nf- kappab inhibitors |
| 03/26/2009 | CA2699280A1 Method of treating hepatitis c patients |
| 03/26/2009 | CA2698397A1 Method of conferring a protective immune response to norovirus |
| 03/26/2009 | CA2687689A1 Triazole-based aminoglycoside-peptide conjugates and methods of use |
| 03/25/2009 | EP2039761A1 Influenza vaccine composition |
| 03/25/2009 | EP2039703A1 Toxin detection method |
| 03/25/2009 | EP2039686A1 Dihydropyrimidine compounds and their uses in preparation of medicaments for treating and preventing antiviral diseases |
| 03/25/2009 | EP2039681A1 Cycloalkene derivatives, process for production of the derivatives, and use of the same |
| 03/25/2009 | EP2039369A1 Treatment of fungal infections |
| 03/25/2009 | EP2039368A2 Methods for preventing reactivation of latent virus and controlling virus replication |
| 03/25/2009 | EP2039361A2 Use of immunomodulatory compounds |
| 03/25/2009 | EP2039358A1 Pharmaceutical compositions comprising a macrolide and an acid |
| 03/25/2009 | EP2038415A1 Dph2 gene deletion mutant and uses thereof |
| 03/25/2009 | EP2038306A1 Anti-nkg2a antibodies and uses thereof |
| 03/25/2009 | EP2038290A1 Modulators of toll-like receptor 7 |
| 03/25/2009 | EP2038286A1 Pyrro[1,2-b]pyridazinone compounds |
| 03/25/2009 | EP2038275A2 Novel pyridazine compound and use thereof |
| 03/25/2009 | EP2038262A2 Triazole compounds that modulate hsp90 activity |
| 03/25/2009 | EP2038253A1 Biphenyl derivatives and their use in treating hepatitis c |
| 03/25/2009 | EP2038011A2 Pathogen - controlling products |
| 03/25/2009 | EP2037937A2 Tri and tetra-oligo-saccharides suitable as agglutination agents for enteric pathogens |
| 03/25/2009 | EP2037934A2 An anti-viral composition for the topical treatment of herpes labialis (cold sores) and method for use thereof |
| 03/25/2009 | EP2037872A2 Compositions comprising betulonic acid |
| 03/25/2009 | EP2000469A9 Acylaminopiperidine compound |
| 03/25/2009 | EP1841765B1 Imidazo[4,5-c]pyridine compound and method of antiviral treatment |
| 03/25/2009 | EP1460999B1 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof |
| 03/25/2009 | CN101395182A Recombinant antibodies for treatment of respiratory syncytial virus infections |
| 03/25/2009 | CN101395181A Influenza antibodies, compositions, and related methods |
| 03/25/2009 | CN101395172A Novel antimicrobial peptides and use thereof |
| 03/25/2009 | CN101395143A Aza heterocyclics for the treatment of malaria or aids |
| 03/25/2009 | CN101394868A Strong immune induction by using combination of adenovirus type-5/type-35 vector and vaccinia virus mva vector |
| 03/25/2009 | CN101394866A Stabilizer for hydrophobic compounds |
| 03/25/2009 | CN101394864A Compositions that include hemagglutinin, methods of making and methods of use thereof |
| 03/25/2009 | CN101394854A Novel use of antihistamine agents for the preventive or early treatment of inflammatory syndromes, in particular those triggered by togaviruses |
| 03/25/2009 | CN101394852A Heterocyclic aspartyl protease inhibitors, preparation and use thereof |
| 03/25/2009 | CN101392261A Modified highly pathogenic porcine reproductive and respiratory syndrome virus ORF5 gene and application |
| 03/25/2009 | CN101392256A Gene synthesis of wild boar alpha-interferon, vector construction and method for producing outcome |
| 03/25/2009 | CN101392239A Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 03/25/2009 | CN101392232A Application of dominant suppressing mutant F427D as anthrax bacillus toxin inhibitor and vaccine |
| 03/25/2009 | CN101392229A Engineering strain for directly producing gernebcin and use thereof |
| 03/25/2009 | CN101392021A Protective antigen composition capable of excitating organism to generate immunity against plague and use thereof |
| 03/25/2009 | CN101392020A Musca domestic pupae natural antimicrobial peptide products and preparation method and use thereof |
| 03/25/2009 | CN101391986A Fluorine triazole ethers derivates and salt with antimicrobial activity, preparation method and medical use |
| 03/25/2009 | CN101391985A Triazole onium compound with antimicrobial activity, preparation method and medical use |
| 03/25/2009 | CN101391103A Medicine composition for preventing and treating AIDS viral infection |
| 03/25/2009 | CN101391102A Production technique of immunoglobulin compounding agent capable of preventing and treating poultry respiratory disease |
| 03/25/2009 | CN101391069A Traditional Chinese medicine for treating tuberculosis |
| 03/25/2009 | CN101391057A Medicine for preventing and treating porcine reproductive and respiratory syndrome |
| 03/25/2009 | CN101391044A External traditional Chinese medicine for treating zoster, herpes simplex or the other viral disease and preparation method thereof |
| 03/25/2009 | CN101391040A External medicine for treating foot and mouth disease |
| 03/25/2009 | CN101391017A Medicine for treating hog cholera |
| 03/25/2009 | CN101391013A Traditional Chinese medicine composition for treating skin disease and preparation method thereof |
| 03/25/2009 | CN101390995A Medicine for preventing and treating swine influenza |
| 03/25/2009 | CN101390994A Medicine for treating herpes zoster |
| 03/25/2009 | CN101390970A Traditional Chinese medicine for treating hepatitis B and preparation method thereof |
| 03/25/2009 | CN101390965A Veterinary traditional Chinese herb medicine for treating livestock and poultry bacterial and viral infectious diseases and preparation method thereof |
| 03/25/2009 | CN101390956A Double coptis injection and preparation method thereof |
| 03/25/2009 | CN101390921A Composition of starwort total glycopeptides and total flavone and preparation method and uses thereof |
| 03/25/2009 | CN101390920A Traditional Chinese medicine for livestock and poultry and preparation method thereof |
| 03/25/2009 | CN101390869A Use of high-purity forsythin in preparing bacteriostasis, antivirus and other medicine |